[go: up one dir, main page]

HRP20120003T1 - Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom - Google Patents

Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom Download PDF

Info

Publication number
HRP20120003T1
HRP20120003T1 HR20120003T HRP20120003T HRP20120003T1 HR P20120003 T1 HRP20120003 T1 HR P20120003T1 HR 20120003 T HR20120003 T HR 20120003T HR P20120003 T HRP20120003 T HR P20120003T HR P20120003 T1 HRP20120003 T1 HR P20120003T1
Authority
HR
Croatia
Prior art keywords
active ingredient
complex
glycine
basic amino
ingredient complex
Prior art date
Application number
HR20120003T
Other languages
English (en)
Croatian (hr)
Inventor
Franckowiak Gerhard
Ledwoch Wolfram
Schweinheim Eberhard
Hayauchi Yutaka
Original Assignee
Bayer Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36649662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20120003(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma Aktiengesellschaft filed Critical Bayer Pharma Aktiengesellschaft
Publication of HRP20120003T1 publication Critical patent/HRP20120003T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • C07C69/145—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157—Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HR20120003T 2005-06-02 2012-01-02 Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom HRP20120003T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005025283A DE102005025283A1 (de) 2005-06-02 2005-06-02 Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
PCT/EP2006/004799 WO2006128600A2 (de) 2005-06-02 2006-05-20 Stabiler wirkstoffkomplex von salzen der o-acetylsalicylsäure mit basischen aminosäuren und glycin

Publications (1)

Publication Number Publication Date
HRP20120003T1 true HRP20120003T1 (hr) 2012-01-31

Family

ID=36649662

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20120003T HRP20120003T1 (hr) 2005-06-02 2012-01-02 Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom

Country Status (32)

Country Link
US (1) US8063243B2 (zh)
EP (1) EP1890994B1 (zh)
JP (1) JP2008542316A (zh)
KR (1) KR101347522B1 (zh)
CN (1) CN101248036B (zh)
AR (1) AR057341A1 (zh)
AT (1) ATE526974T1 (zh)
AU (1) AU2006254429B2 (zh)
BR (1) BRPI0610734A2 (zh)
CA (1) CA2610194C (zh)
CR (1) CR9556A (zh)
CY (1) CY1112185T1 (zh)
DE (1) DE102005025283A1 (zh)
DK (1) DK1890994T3 (zh)
ES (1) ES2373917T3 (zh)
HR (1) HRP20120003T1 (zh)
IL (1) IL187772A (zh)
MA (1) MA29604B1 (zh)
MX (1) MX2007014988A (zh)
NO (1) NO20076592L (zh)
NZ (1) NZ563871A (zh)
PL (1) PL1890994T3 (zh)
PT (1) PT1890994E (zh)
RS (1) RS52111B (zh)
RU (1) RU2433995C2 (zh)
SG (1) SG162744A1 (zh)
SI (1) SI1890994T1 (zh)
TN (1) TNSN07452A1 (zh)
TW (1) TWI374740B (zh)
UA (1) UA89827C2 (zh)
WO (1) WO2006128600A2 (zh)
ZA (1) ZA200710251B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
AU2010263409B2 (en) * 2009-06-25 2013-09-05 Tetra, Sia Novel acetylsalicylic acid salts
CA2766048A1 (en) 2009-06-25 2010-12-29 Tetra, Sia Novel acetylsalicylic acid salts
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
TWI478715B (zh) * 2010-12-03 2015-04-01 Tetra Sia 新穎乙醯柳酸鹽
RU2011132483A (ru) * 2011-08-02 2013-02-10 Елена Александровна Моренко Биологически активный продукт для применения в ветеринарии и животноводстве, способ его получения и способы повышения выживаемости, стимуляции роста, иммуностимуляции и повышения общей неспецифической резистентности организма сельскохозяйственных животных
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
ITMI20121144A1 (it) * 2012-06-28 2013-12-29 Dipharma Francis Srl Procedimento per la preparazione di un sale di un farmaco antinfiammatorio non steroideo
LV14963B (lv) 2013-06-28 2015-10-20 Tetra, Sia Endoteliālās disfunkcijas korektors
WO2017144149A1 (de) * 2016-02-23 2017-08-31 Merck Patent Gmbh Glycin-partikel
DK3558920T3 (da) * 2016-12-23 2021-07-05 Aspiair Gmbh Forbedret syntese af lysinacetylsalicylat-glycin-partikler
CA3064012A1 (en) 2017-05-30 2018-12-06 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
CN112592286B (zh) * 2020-11-23 2024-02-02 蚌埠丰原医药科技发展有限公司 一种阿司匹林与碱性氨基酸的络合物的制备方法
JP2025501974A (ja) 2022-01-05 2025-01-24 アスピエアー ゲーエムベーハー アセチルサリチル酸リジン・グリシン粒子の改良された合成

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS5665816A (en) * 1979-11-01 1981-06-03 Green Cross Corp:The Acetylsalicylate pharmaceutical for injection
US4446132A (en) * 1982-03-11 1984-05-01 Dynatech Laboratories Incorporated Nontoxic aspirin composition
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
FR2741534B1 (fr) * 1995-11-23 1998-09-11 Mazal Pharma Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol
JPH11222425A (ja) * 1997-10-27 1999-08-17 Ss Pharmaceut Co Ltd 関節疾患治療用関節内投与製剤
DE10034802A1 (de) 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
RU2203064C2 (ru) * 2001-03-11 2003-04-27 Каменев Виктор Федорович Способ лечения аспириновой бронхиальной астмы
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
DE102004025535A1 (de) * 2004-05-25 2005-12-22 Bayer Healthcare Ag Kombination von Salzen der o-Acetylsalicylsäure und Alpha-Glucosidase-Inhibitoren

Also Published As

Publication number Publication date
AU2006254429B2 (en) 2011-11-10
AU2006254429A1 (en) 2006-12-07
CA2610194A1 (en) 2006-12-07
IL187772A (en) 2013-06-27
ES2373917T3 (es) 2012-02-10
CR9556A (es) 2008-03-03
ATE526974T1 (de) 2011-10-15
CA2610194C (en) 2013-11-05
RS52111B (en) 2012-08-31
MX2007014988A (es) 2008-02-15
TW200716138A (en) 2007-05-01
BRPI0610734A2 (pt) 2010-07-20
EP1890994A2 (de) 2008-02-27
NO20076592L (no) 2007-12-20
IL187772A0 (en) 2008-08-07
RU2007148709A (ru) 2009-07-20
CN101248036A (zh) 2008-08-20
DK1890994T3 (da) 2012-02-06
ZA200710251B (en) 2009-09-30
MA29604B1 (fr) 2008-07-01
DE102005025283A1 (de) 2006-12-07
CN101248036B (zh) 2016-03-16
KR20080030578A (ko) 2008-04-04
KR101347522B1 (ko) 2014-01-02
TNSN07452A1 (en) 2009-03-17
WO2006128600A2 (de) 2006-12-07
US8063243B2 (en) 2011-11-22
WO2006128600A3 (de) 2007-04-26
JP2008542316A (ja) 2008-11-27
PT1890994E (pt) 2012-01-05
NZ563871A (en) 2011-02-25
CY1112185T1 (el) 2015-12-09
EP1890994B1 (de) 2011-10-05
AR057341A1 (es) 2007-11-28
TWI374740B (en) 2012-10-21
SI1890994T1 (sl) 2012-02-29
RU2433995C2 (ru) 2011-11-20
UA89827C2 (ru) 2010-03-10
SG162744A1 (en) 2010-07-29
US20090226524A1 (en) 2009-09-10
PL1890994T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
HRP20120003T1 (hr) Stabilni kompleks aktivnog sastojka soli o-acetilsalicilne kiseline sa osnovnim aminokiselinama i glicinom
CA2416288A1 (en) Stable salts of o-acetylsalicylic acid with basic amino acids
CN101851213A (zh) 3，6-双(4-双反丁烯二酰基氨丁基)-2，5-二酮哌嗪及其盐取代物的合成方法
CN103113154B (zh) 一种防除水稻田杂草的药肥颗粒剂及其制备方法
CH636842A5 (de) Alpha-fluormethylderivate des putrescins.
JPS6033823B2 (ja) サリチルアニリド誘導体及びその製造方法
EP3245177B1 (en) Flowable mixture including elemental sulfur and hydrated clay and method for producing the same
DE3152071C2 (de) Taurinderivate, deren Herstellung und Verwendung in Arzneimitteln
EP1124824B1 (de) Chromenon- und chromanonderivate als integrinhemmer
RS50123B (sr) Antagonist serotonin receptora inkapsuliran u biorazgradivom polimeru i postupak njegovog dobijanja
JPS5984822A (ja) 獣医用鎮痛剤
JP2021512138A (ja) ２−（αヒドロキシペンチル）安息香酸の有機アミンエステル誘導体薬物
DE2235935A1 (de) Neue derivate von trijodierten aminobenzolcarbonsaeuren, ein verfahren zu deren herstellung und deren verwendung
CN101326172A (zh) 茉莉酮酸酯衍生物、药物组合物及它们的使用方法
CN107056396A (zh) 一种复合型氨基酸肥料及其制备方法
He et al. Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
CN101971833A (zh) 氟虫双酰胺与鱼藤酮复配杀虫水分散粒剂及其制备方法
CN102742595A (zh) 一种含有氯溴异氰尿酸与杀虫剂的药物组合物及其制剂
AT390948B (de) Verfahren zur herstellung von neuen benzamid-derivaten
Tena-Solsona et al. Self-assembled multivalent (SAMul) ligand systems with enhanced stability in the presence of human serum
JPS5849433A (ja) マイクロカプセルの製法
CN109336705A (zh) 一种微碳超敏素复合肥
CN102246813A (zh) 阿维·毒死蜱乳油
RU2665411C1 (ru) Способ получения нанокапсул стрептоцида в ксантановой камеди
ES2729732B2 (es) Transformación catalítica de fases mediante metales en compuestos quirales